Cytek Biosciences (CTKB) Operating Income Growth (3y) (2023 - 2026)
Cytek Biosciences (CTKB) Operating Income Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | 3.16% |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | 19.80% |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 6.17% |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 31.84% |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | 24.88% |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | 35.44% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 9.04% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | 60.19% |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 13.06% |
| 10 | Cytek Biosciences | 604.58 Mn | 530.73 Mn | 28.34 Mn | -7.69% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -7.69% |
| Mar 31, 2026 | -14.93% |
| Dec 31, 2025 | -309.35% |
| Sep 30, 2025 | -106.13% |
| Jun 30, 2025 | -128.46% |
| Mar 31, 2025 | -85.21% |
| Dec 31, 2024 | 31.37% |
| Sep 30, 2024 | -51.34% |
| Jun 30, 2024 | -61.82% |
| Mar 31, 2024 | -125.60% |
| Dec 31, 2023 | -26.36% |
| Sep 30, 2023 | -43.53% |
| Jun 30, 2023 | -247.24% |